SCHEMBL608325

SCHEMBL608325

NC(=O)c1ccnc(C(N)=O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5C P41229 2/20 0.55
KDM5B Q9UGL1 2/20 0.55
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
KDM6B O15054 1/20 0.55
TET3 O43151 1/20 0.55
KDM4A O75164 1/20 0.55
BBOX1 O75936 1/20 0.55
MAPT P10636 1/20 0.55
KDM5A P29375 1/20 0.55
ASPH Q12797 1/20 0.55
KDM4D Q6B0I6 1/20 0.55
TET2 Q6N021 1/20 0.55
ALKBH5 Q6P6C2 1/20 0.55
KDM7A Q6ZMT4 1/20 0.55
KDM8 Q8N371 1/20 0.55
TET1 Q8NFU7 1/20 0.55
EGLN2 Q96KS0 1/20 0.55
FTO Q9C0B1 1/20 0.55
EGLN1 Q9GZT9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29830568 1.00 KDM5C (0.55) KDM5CKDM5BALDH1A1KDM4EKDM6B
Hydrochloric Acid SCHEMBL28255645 0.98 KDM5C (0.53) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL17712926 0.88 KDM4E (0.74) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL7720509 0.88 KDM5C (0.74) KDM5CKDM5BALDH1A1KDM4EKDM6B
Pyrrole SCHEMBL28266340 0.88 KDM5C (0.44) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL19642219 0.88 KDM5C (0.44) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL20285457 0.86 ALDH1A1 (0.50) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL8061432 0.86 ALDH1A1 (0.50) KDM5CKDM5BALDH1A1KDM4EKDM6B
SCHEMBL9561742 0.83 KDM5C (0.47) KDM5CKDM5BALDH1A1KDM4EKDM6B
Phenylacetylene SCHEMBL19439259 0.82 ALDH1A1 (0.44) KDM5CKDM5BALDH1A1KDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153646-B Pyridine dicarboxamide derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2022-08-02 CN claimed
CN-114249683-A Synthesis method of N-hydroxyimide compound 中国石化扬子石油化工有限公司 2022-03-29 CN claimed
CN-108884070-B Pyridyl derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2021-07-02 CN claimed
CN-1649581-A Substituted 3-amino-thieno [2, 3-b ] pyridine-2-carboxylic acid amide compounds, preparation method and uses thereof BOEHRINGER INGELHEIM PHARMA (US) 2005-08-03 CN claimed
WO-1998033786-A9 ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS 1998-12-30 WO claimed
US-5512586-A FOR INHIBITING METABOLISM OF COLLAGEN; IMMUNOSUPPRESSANTS HOECHST AKTIENGESELLSCHAFT (DE) 1996-04-30 US claimed
US-20230331715-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2023-10-19 US disclosed
US-20230278997-A1 BICYCLO[1.1.1]PENTANE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2023-09-07 US disclosed
CN-109153646-B Pyridine dicarboxamide derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2022-08-02 CN disclosed
WO-2022155419-A1 INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS ESCAPE Bio, Inc. (US) 2022-07-21 WO disclosed
CN-114249683-A Synthesis method of N-hydroxyimide compound 中国石化扬子石油化工有限公司 2022-03-29 CN disclosed
CN-108884070-B Pyridyl derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2021-07-02 CN disclosed
US-10752640-B2 Compounds active towards bromodomains NUEVOLUTION A/S (DK) 2020-08-25 US disclosed
US-5516901-A Preparation of reactive phthalocyanine dyes BASF AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5302708-A Colorfastness HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-12 US disclosed
EP-0587137-A1 Adsorbate comparised of an auxiliary agent mixture and a non-solid active agent for the manufacture of pharmaceutical preparations HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-16 EP disclosed
US-5260323-A 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-09 US disclosed
US-5147553-A Separation of fluid mixture IONICS, INCORPORATED (US) 1992-09-15 US disclosed
CN-1057649-A 2,4-and 2,5-substituted pyridine-N-oxides, its preparation method and application HOECHS AG (DE) 1992-01-08 CN disclosed
US-4745187-A Process for the preparation of water-soluble phthalocyanine dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1988-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331715-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HAVCR2, NR1I3, NR1H4 KDM5C 4224/4885KDM5B 4583/4885ALDH1A1 114/4885
US-10752640-B2 Compounds active towards bromodomains BRD4, BRD3, BRDT KDM5C 781/4885KDM5B 870/4885ALDH1A1 3848/4885
US-20230278997-A1 BICYCLO[1.1.1]PENTANE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HAVCR2, CYP1B1, CYP7A1 KDM5C 2879/4885KDM5B 3228/4885ALDH1A1 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.